Oculus Innovative Sciences, Inc. Announces Completion Of Agreements Required For IPO By Company’s Subsidiary, Ruthigen

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that as of January 31, 2014, Oculus has entered into certain new and amended agreements with its wholly owned subsidiary, Ruthigen Inc., which are required for Ruthigen’s continued IPO process.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC